
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
| Review | Status | Reviewer | Date | Notes |
|---|---|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. | ||
| clinical review | not_started | Awaiting clinician review; check the classification as type 2 diabetes (GAD antibodies negative, C-peptide preserved, no ketosis), metformin alone at diagnosis with an A1c of 9.4 percent by his choice, the delay of the SGLT2 inhibitor until albuminuria was confirmed, losartan for stage 1 hypertension with albuminuria, the statin at 35, the adapted IDF-DAR fasting plan, the missed three-month A1c and post-statin lipid checks while he travelled, the prednisone course in a man with diabetes, and asthma on GINA track 1. | ||
| provenance review | not_started | He died in 1902; the recent-death rule does not apply. Claims rest on the Belur Math biography, three chapters of Swami Nikhilananda's biography, and seven of his own letters in the Complete Works (via Wikisource). His diabetes (1897), insomnia (1897), asthma (1898 to 1901) and albuminuria are documented in his own words; the classification of his diabetes, his kidney disease and the cause of his death are R. | ||
| safe messaging review | not_started | No mental health or substance claim is made; mood screens are synthetic and negative. His monastic life, diet and fasts are described with respect and left to his choice. His death is recorded once, with the physicians' and the monks' understandings side by side. No disciple, brother monk or other real person is named or given a role in the modern episode. |
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|---|---|---|
| 2026-10-27 Progress note 06 (C-CDA) | A1c three months after the change in therapy | Quarterly after a change in therapy | Missed: due three months after the metformin dose increase, while he was travelling in the mountains, and he could not find a laboratory. No harm resulted judging by today's A1c of 6.9 percent and his monthly fasting readings of 110 to 135 mg/dL. Corrective action: a point-of-care or mail-in A1c kit and a video visit are now arranged before any journey longer than two months |
| 2026-10-27 Progress note 06 (C-CDA) | Lipid panel after starting a statin | Four to twelve weeks after starting | Missed: due six to twelve weeks after starting atorvastatin, during his travels; done today, seven months after starting: LDL 84, triglycerides 146. No harm resulted. Corrective action: as for the A1c, testing before long journeys is now planned |
| Visit | Type | Item | Status | Detail |
|---|---|---|---|---|
| 2026-02-16 Progress note 02 (C-CDA) | Referral | Dilated eye examination or retinal photographs | Ordered | Retinal photographs booked for the next visit |
| 2026-02-16 Progress note 02 (C-CDA) | Self-management | Diabetes self-management education and medical nutrition therapy | Referred | Dietitian this week: a mostly vegetarian plan built on his monastery meals |
| 2026-03-09 Progress note 03 (C-CDA) | Prevention | Hepatitis B screening | Ordered | Born in a country where hepatitis B is common; drawn today |
| 2026-03-09 Progress note 03 (C-CDA) | Prevention | Latent tuberculosis infection screening | Ordered | Born in a country where tuberculosis is common; interferon-gamma release assay drawn today |
| 2026-03-09 Progress note 03 (C-CDA) | Prevention | HIV and hepatitis C screening | Ordered | Once-in-adulthood tests drawn today with his agreement |
| 2026-03-09 Progress note 03 (C-CDA) | Prevention | Diabetic eye examination | Ordered | Retinal photographs booked for the next visit |
| 2026-03-23 Progress note 04 (C-CDA) | Self-management | Insomnia treatment | Referred | Cognitive behavioral therapy for insomnia by video |
| Claim | Statement | Certainty |
|---|---|---|
| CLM-0014 | Retrospective interpretation: diabetes beginning at about 34 in a man of South Asian ancestry who called it hereditary, who lived five more years without insulin, and whose thirst and sugar came and went with diet and rest, is most consistent with type 2 diabetes; slowly progressive autoimmune diabetes cannot be excluded from the record. | possible |
| CLM-0015 | Retrospective interpretation: albuminuria from about 1898, a diagnosis of Bright's disease, a bleed in the eye and swelling of the feet late in his life are consistent with diabetic kidney disease, perhaps with high blood pressure, but no measurement survives and other kidney or heart disease cannot be excluded. | possible |
| CLM-0016 | Retrospective interpretation: his sudden death, which many accounts describe as the rupture of a blood vessel in the brain, could have been a brain hemorrhage or a heart event; the physicians' "apoplexy or sudden failure of the heart" does not decide between them, and his followers understand it as samadhi. | disputed |
None.
None.
Every note in the record, with its type. All clinical content is synthetic.
| Date | Result | Value | Flag |
|---|---|---|---|
| 2026-02-09 | Glucose (random) | 246 mg/dL (high) | High |
| 2026-10-20 | Peak expiratory flow | 330 L/min (low) | Low |
| 2026-02-16 | Hemoglobin A1c | 9.4% (high) | High |
| 2026-02-16 | Glucose (fasting) | 172 mg/dL (high) | High |
| 2026-02-16 | Urine albumin-to-creatinine ratio | 46 mg/g (high) | High |
| 2026-02-16 | Total cholesterol | 214 mg/dL (high) | High |
| 2026-02-16 | HDL cholesterol | 36 mg/dL (low) | Low |
| 2026-02-16 | Triglycerides | 228 mg/dL (high) | High |
| 2026-02-16 | LDL cholesterol | 132 mg/dL (high) | High |
| 2026-03-23 | Urine albumin-to-creatinine ratio | 41 mg/g (high) | High |
| 2026-10-27 | Hemoglobin A1c | 6.9% (high) | High |
| 2026-10-27 | Glucose (fasting) | 124 mg/dL (high) | High |
| 2026-10-27 | Urine albumin-to-creatinine ratio | 34 mg/g (high) | High |
| 2026-10-27 | HDL cholesterol | 39 mg/dL (low) | Low |
| 2026-10-27 | FEV1 before bronchodilator | 2.95 L (low) | Low |
| 2026-10-27 | FEV1 percent predicted before bronchodilator | 77% (low) | Low |
| 2026-10-27 | FEV1/FVC before bronchodilator | 0.66 (low) | Low |
| 2026-10-27 | FeNO | 44 [ppb] (high) | High |